Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-25T17:36:57.358Z Has data issue: false hasContentIssue false
  • English
  • Français

The Therapeutic Potential of 5-HT1B Autoreceptors and Heteroreceptors and 5-HT-Moduline in CNS Disorders

Published online by Cambridge University Press:  07 November 2014

Hala Sarhan  and
Gilles Fillion
Get access Rights & Permissions [Opens in a new window]

Abstract

The endogenous peptide 5-HT–moduline has been characterized as a novel neuropeptide that binds to 5-HT1B receptors in the brain areas in which it is released. By inducing structural changes in these receptors, this peptide prevents 5-HT binding, thereby desensitizing the receptors and inhibiting serotonergic function. This novel mechanism may help to explain differential effects of the serotonergic system in varying areas of the brain that are innervated by the same or few neurons. In addition, dysfunction or disruption of the 5-HT–moduline system may contribute to psychiatric disorders such as depression and anxiety, and may have important implications for the development of new therapeutic agents for these disorders.

Type
Feature Article
Information
CNS Spectrums , Volume 3 , Issue 8: Serotonin Subsystems , September 1998 , pp. 50 - 58
Copyright
Copyright © Cambridge University Press 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Rousselle, JC, Massot, O, Delepierre, M, Zifa, E, Rousseau, B, Fillion, G. Isolation and characterization of an endogenous peptide from rat brain interacting specifically with the serotonergic1B receptor subtypes. J Biol Chem. 1996;271:1–10.Google Scholar
2.Massot, O, Rousselle, JC, Fillion, MP, et al.5-hydroxytrypt–amine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors. Mol Pharmacol. 1996;50:752–762.Google Scholar
3.Seguin, L, Seznec, JC, Fillion, G. The endogenous cerebral tetrapeptide 5-HT-moduline reduces in vivo the functional activity of central 5-HT1B receptors in the rat. Neurosci Res. 1997;27:277–280.Google Scholar
4.Zifa, E, Fillion, G. 5-hydroxytryptamine receptors. Pharmacol Rev. 1992;44:401–458.Google Scholar
5.Soghomonian, JJ, Descarries, L, Watkins, KC. Serotonin innervation in adult rat neostriatum. II: ultrastructural features: a radioautographic and immunocytochemical study. Brain Res. 1989;481:67–86.Google Scholar
6.Descarries, L, Audet, MA, Doucet, G, et al.Morphology of central serotonin neurons: brief review of quantified aspects of their distribution and ultrastructural relationships. Ann NY Acad Sci. 1990;600:81–92.Google Scholar
7.Baumgarten, HG, Grozdanovic, Z. Anatomy of central sero-toninergic projection systems. In: Baumgarten, HG, Göthert, M, eds. Serotoninergie Neurons and 5-HT Receptors in the CNS. Handbook of Experimental Pharmacology. London, England: Springer Verlag; 1997:41–89.Google Scholar
8.Audet, MA, Descarries, L, Doucet, G. Quantified regional and laminar distribution of the serotonin innervation in the anterior half of adult rat cerebral cortex. J Chem Neuroanat. 1989;2:29–44.Google Scholar
9.Moukhles, H, Bosler, O, Bolam, JP, et al.Quantitative and morphometric data indicate precise cellular interactions between serotonin terminals and postsynaptic targets in rat substantia nigra. Neuroscience. 1997;76:1159–1171.Google Scholar
10.Agnati, LF, Bjelke, B, Fuxe, K. Volume versus wiring transmission in the brain: a new theoretical frame for neuropsychopharmacology. Med Res Rev. 1995;15:33–45.Google Scholar
11.Agnati, LF, Zoli, M, Stromberg, I, Fuxe, K. Intercellular communication in the brain: wiring versus volume transmission. Neuroscience. 1995;69:711–726.Google Scholar
12.Boess, FG, Martin, IL. Molecular biology of 5-HT receptors. Neuropharmacology. 1994;33:275–317.Google Scholar
13.Hoyer, D, Clarke, DE, Fozard, JR, et al.VII International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev. 1994;46:157–203.Google Scholar
14.Hoyer, D, Martin, G. 5-HT receptor classification and nomenclature: towards a harmonization with the human genome. Neuropharmacology. 1997;36:419–428.Google Scholar
15.Maura, G, Raiteri, M. Cholinergic tenninals in rat hippocampus possess 5-HT1B receptors mediating inhibition of acetylcholine release. Eur J Pharmacol. 1986;129:333–337.CrossRefGoogle ScholarPubMed
16.Maura, G, Marcoli, M, Tortarolo, M, Andrioli, GC, Raiteri, M. Glutamate release in human cerebral cortex and its modulation by 5-hydroxytryptamine acting at h 5-HT1D receptors. Br J Pharmacol. 1998;123:45–50.Google Scholar
17.Hoyer, D, Schoeffter, P, Waeber, C, Palacios, JM. Serotonin 5-HT1D receptors. Ann NY Acad Sci. 1990;600:168–181. Review.Google Scholar
18.Fillion, G, Fillion, MP. Modulation of affinity of postsynaptic serotonin receptors by antidepressant drugs. Nature. 1981;292:349–351.Google Scholar
19.Rousselle, JC, Plantefol, M, Fillion, MP, et al.Specific interaction of 5-HT—moduline with human 5-HT1B as well as 5-HT1D receptors expressed in transfected cultured cells. Naunyn Schmiedebergs Arch Pharmacol. In press.Google Scholar
20.Cloez-Tayarani, I, Cardona, A, Rousselle, JC, Massot, O, Edelman, L, Fillion, G. Autoradiographic characterization of [3H]-5-HT—moduline binding sites in rodent brain and their relationship to 5-HT1B receptors. Proc Natl Acad Sci USA. 1997;94:9899–9904.Google Scholar
21.Cloëz-Tayarani, I, Cardona, A, Sarhan, H, et al.Mapping of 5-HT—moduline binding sites in guinea-pig brain by film and digital autoradiography. Brain Res. In press.Google Scholar
22.Grimaldi, B, Fillion, MP, Bonnin, A, Rousselle, JC, Massot, O, Fillion, G. Immunocytochemical localization of neurons expressing 5-HT—moduline in the mouse brain. Neuropharmacology. 1997;36:1079–1087.Google Scholar
23.Plantefol, M, Rousselle, JC, Fillion, G. 5-HT—moduline metabolism in mammalian brain: identification of two enzymatic activities. Eur Neuropsychopharmacol. In press.Google Scholar
24.Ischia, R, Lovisetti-Scamihom, P, Hogue-Angeletti, R, Wolkersdorfer, M, Winkler, H, Fisher-Colbrie, R. Molecular cloning and characterization of NESP55, a novel chromogranin-like precursor of a peptide with 5-HT1B receptor antagonist activity. J Bid Chem. 1997;17:11657–11662.Google Scholar
25.Briley, M, Chopin, P, Moret, C. Effect of serotonergic lesion on “anxious” behaviour measured in the elevated plus-maze test in the rat. Psychopharmacohgy. 1990;1:187–189.Google Scholar
26.Briley, M, Chopin, P. Is anxiety associated with a hyper- or hypo-serotonergic state? In: Palomo, T, Archer, T, eds. Studying Brain Disorders. Vol. 1, Depressbn, Anxiety and Drug Abuse Disorders. Madrid, Spain: Editorial Complutense, Donoso Cortes; 1994:197–209.Google Scholar
27.Kawahara, H, Yoshida, M, Yokoo, H, Nishi, M, Tanaka, M. Psychological stress increases serotonin release in the rat amygdala and prefrontal cortex assessed by in vivo micro-dialysis. Neurosci Lett. 1993;162:81–84.Google Scholar
28.Vahabzadeh, A, Fillenz, M. Comparison of stress-induced changes in noradrenergic and serotonergic neurons in the rat hippocampus using microdialysis. Eur J Neurosci. 1994;6:1205–1212.Google Scholar
29.Pei, Q, Zetterstrom, T, Fillenz, M. Tail pinch-induced changes in the turnover and release of dopamine and 5-hydroxytryptamine in different brain regions of the rat. Neuroscience. 1990;35:133–138.CrossRefGoogle ScholarPubMed
30.Clement, HW, Schäfer, F, Ruwe, C, Gemsa, D, Wesemann, W. Stress-induced changes of extracellular 5-hydroxyin-doleacetic acid concentrations followed in the nucleus raphe dorsalis and the frontal cortex of the rat. Brain Res. 1993;614:117–124.CrossRefGoogle Scholar
31.Bolaños-Jiménez, F, Manhaes De Castro, R, Seguin, L, et al.Effects of stress on the functional properties of pre- and postsynaptic 5-HT1B receptors in the rat brain. Eur J Pharmacol. 1995;294:531–540.Google Scholar
32.Bonnin, A, Grimaldi, B, Fillion, MP, Fillion, G. Acute stress induces a differential increase of 5-HT—moduline levels in various rat brain areas. Eur Neuropsychopharmacol. In press.Google Scholar
33.Gamara, GD, Xavier, MH, Denardin, JD, et al.The effects of acute and repeated restraint stress on the nociceptive response in rats. Physiol Behav. 1998;63:693–697.Google Scholar
34.Grimaldi, B, Sibella-Arguelles, C, Bonnin, A, et al.Control of the serotonergic activity and gene expression by 5-HT—moduline. Eur Neuropsychopharmacol. In press.Google Scholar
35.Hartig, PR. Molecular biology and transductional characteristics of 5-HT receptors. In: Baumgarten, HG, Göthert, M, eds. Serotonergic Neurons and 5-HT Receptors in the CNS. Handbook of Experimental Pharmacology. Chapter 7. London, England: Springer Verlag; 1997:175–212.Google Scholar
36.Sarhan, H, Cloëz-Tayarani, I, Massot, O, Fillion, MP, Fillion, G. 5-HT1B receptor stimulation inhibits the K+-evoked [3H] dopamine release from rat striatal synaptosomes. Eur Newopsychopharmacol. In press.Google Scholar
37.Bentué-Ferrer, D, Reymann, JM, Rousselle, JC, Massot, O, Bourin, M, Allain, H, Fillion, G. 5-HT—moduline, a 5-HT1B/1D receptor endogenous modulator, interacts with dopamine release measured in vivo by microdialysis. Eur J Pharmacol. In press.Google Scholar
38.Zohar, J. Is 5-HT1D involved in obsessive-compulsive disorder? Eur Neuropsychopharmacol. 1996;6:54–55.Google Scholar
39.Lucas, JJ, Hen, R. New players in the 5-HT receptor field: genes and knockouts. Trends Pharmacol Sci. 1995;16:246–252.Google Scholar
40.Saudou, F, Amara, DA, Dierich, A, et al.Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science. 1994;265:1875–1878.CrossRefGoogle Scholar
41.Crabbe, JC, Philips, TJ, Feller, DJ, et al.Elevated alcohol consumption in null mutant mice lacking 5-HT1B serotonin receptors. Nat Genet. 1996;14:98–101.Google Scholar